Autoencoder Based Feature Selection Method for Classification of Anticancer Drug Response
暂无分享,去创建一个
Yang Wang | Jia Wang | Hong Gu | Pan Qin | Xiaolu Xu | Yang Wang | Hong Gu | Yang Wang | Pan Qin | Jia Wang | Xiaolu Xu
[1] Walter Kolch,et al. Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients , 2015, Science Signaling.
[2] R. Pal,et al. An Ensemble Based Top Performing Approach for NCI-DREAM Drug Sensitivity Prediction Challenge , 2014, PloS one.
[3] C. Nucera,et al. Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer. , 2010, Surgery.
[4] Louxin Zhang,et al. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization , 2017, BMC Cancer.
[5] Sergey V. Kostrov,et al. Alterations in Gene Expression of Proprotein Convertases in Human Lung Cancer Have a Limited Number of Scenarios , 2013, PloS one.
[6] Denis Bertrand,et al. Predicting Cancer Drug Response Using a Recommender System , 2017, bioRxiv.
[7] Fa-Yu Liu,et al. CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck. , 2014, International journal of oncology.
[8] Tamás D. Gedeon,et al. Data Mining of Inputs: Analysing Magnitude and Functional Measures , 1997, Int. J. Neural Syst..
[9] U Schumacher,et al. Regulation of the NRSF/REST gene by methylation and CREB affects the cellular phenotype of small-cell lung cancer , 2010, Oncogene.
[10] C. Watts,et al. Cystatin F Ensures Eosinophil Survival by Regulating Granule Biogenesis , 2016, Immunity.
[11] Emanuel J. V. Gonçalves,et al. A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.
[12] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[13] Howard A. Fine,et al. Predicting in vitro drug sensitivity using Random Forests , 2011, Bioinform..
[14] Chun Xing Li,et al. Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selection , 2015, BMC Cancer.
[15] Tero Aittokallio,et al. Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization , 2016, Bioinform..
[16] Heng Zhao,et al. The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer. , 2014, Biochemical and biophysical research communications.
[17] Elias Chaibub Neto,et al. The Stream Algorithm: Computationally Efficient Ridge-Regression via Bayesian Model Averaging, and Applications to Pharmacogenomic Prediction of Cancer Cell Line Sensitivity , 2013, Pacific Symposium on Biocomputing.
[18] Sridhar Ramaswamy,et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..
[19] Nci Dream Community. A community effort to assess and improve drug sensitivity prediction algorithms , 2014 .
[20] Isidro Cortes-Ciriano,et al. Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel , 2015, Bioinform..
[21] Jun Cao,et al. The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells , 2015, Medical Oncology.
[22] Lynda Chin,et al. MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB , 2016, Clinical Cancer Research.
[23] Andrew H. Beck,et al. PharmacoGx: an R package for analysis of large pharmacogenomic datasets , 2015, Bioinform..
[24] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[25] Juho Rousu,et al. Identification of drug candidates and repurposing opportunities through compound–target interaction networks , 2015, Expert opinion on drug discovery.
[26] Viswanath Gunda,et al. Genome-wide analysis of differentially expressed miRNA in PLX4720-resistant and parental human thyroid cancer cell lines. , 2016, Surgery.
[27] J. C. Correa,et al. Random forests to predict rectal toxicity following prostate cancer radiation therapy. , 2014, International journal of radiation oncology, biology, physics.
[28] E. Seto,et al. HDACs and HDAC Inhibitors in Cancer Development and Therapy. , 2016, Cold Spring Harbor perspectives in medicine.
[29] In-Chul Park,et al. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells. , 2009, International journal of oncology.
[30] Julio Saez-Rodriguez,et al. Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties , 2012, PloS one.
[31] G. Wilkinson,et al. Drug metabolism and variability among patients in drug response. , 2005, The New England journal of medicine.
[32] E. Dı́az-Rodrı́guez,et al. Antitumoral effect of Ocoxin, a natural compound-containing nutritional supplement, in small cell lung cancer , 2018, International journal of oncology.
[33] Witold R. Rudnicki,et al. Feature Selection with the Boruta Package , 2010 .
[34] D. Kerr,et al. Predictive biomarkers: a paradigm shift towards personalized cancer medicine , 2011, Nature Reviews Clinical Oncology.
[35] J. Hecht,et al. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Yi-Ting Fang,et al. Annexin A2 Silencing Induces G2 Arrest of Non-small Cell Lung Cancer Cells through p53-dependent and -independent Mechanisms* , 2012, The Journal of Biological Chemistry.
[37] Laura M. Heiser,et al. A community effort to assess and improve drug sensitivity prediction algorithms , 2014, Nature Biotechnology.
[38] Paul S Mischel,et al. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. , 2009, Cancer research.
[39] Cheng-Yuan Liou,et al. Modeling word perception using the Elman network , 2008, Neurocomputing.
[40] Xiaoqi Zheng,et al. A systematic study on drug-response associated genes using baseline gene expressions of the Cancer Cell Line Encyclopedia , 2016, Scientific Reports.
[41] Diego Franco,et al. Protein distribution of Kcnq1, Kcnh2, and Kcne3 potassium channel subunits during mouse embryonic development. , 2006, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[42] P. Steerenberg,et al. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. , 2010, Annals of the rheumatic diseases.
[43] Xu Wang,et al. Targeting the IDO1 pathway in cancer: from bench to bedside , 2018, Journal of Hematology & Oncology.
[44] Taravat Ghafourian,et al. Differential effects of the oncogenic BRAF inhibitor PLX4032 (vemurafenib) and its progenitor PLX4720 on ABCB1 function. , 2014, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[45] Zhi-Hua Zhou,et al. Exploratory Under-Sampling for Class-Imbalance Learning , 2006, Sixth International Conference on Data Mining (ICDM'06).
[46] V. Bajic,et al. DWFS: A Wrapper Feature Selection Tool Based on a Parallel Genetic Algorithm , 2015, PloS one.
[47] Zhuowen Tu,et al. Similarity network fusion for aggregating data types on a genomic scale , 2014, Nature Methods.
[48] Jun Wang,et al. Predicting Anticancer Drug Responses Using a Dual-Layer Integrated Cell Line-Drug Network Model , 2015, PLoS Comput. Biol..
[49] Yuri Nikolsky,et al. Development of a Drug-Response Modeling Framework to Identify Cell Line Derived Translational Biomarkers That Can Predict Treatment Outcome to Erlotinib or Sorafenib , 2015, PloS one.
[50] Krister Wennerberg,et al. Integrative and Personalized QSAR Analysis in Cancer by Kernelized Bayesian Matrix Factorization , 2014, J. Chem. Inf. Model..
[51] Jesper Tegnér,et al. Consistent Feature Selection for Pattern Recognition in Polynomial Time , 2007, J. Mach. Learn. Res..
[52] Joshua C. Gilbert,et al. An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules , 2013, Cell.
[53] R. Geha,et al. 2. Update on primary immunodeficiency diseases. , 2006, The Journal of allergy and clinical immunology.
[54] Vedrana Milinkovic,et al. Identification of genes associated with non-small-cell lung cancer promotion and progression. , 2010, Lung cancer.
[55] Yanwen Chen,et al. Drug Intervention Response Predictions with Paradigm (DIRPP) Identifies Drug Resistant Cancer Cell Lines and Pathway Mechanisms of Resistance , 2014, Pacific Symposium on Biocomputing.